Terms: = Liver cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
217 results:
1. The long-term efficacy of imatinib with hepatic resection or other local treatment for gastrointestinal stromal tumours liver metastases: a retrospective cohort study.
Wen H; Huang Y; Huang S; Xiao H; Xie W; Zhou Q; Tan L; Ding Y; Liu X; Yu Y; Song Z; Shen S; Chen Z; Zhang X
Int J Surg; 2024 Apr; 110(4):2151-2161. PubMed ID: 38619177
[TBL] [Abstract] [Full Text] [Related]
2. Development of crizotinib-associated renal cyst in a non-small cell lung cancer patient with alk fusion: a case report and review of the literature.
Zhang P; Xu J; Wu Q; Qian J; Wang S
Diagn Pathol; 2024 Apr; 19(1):58. PubMed ID: 38616252
[TBL] [Abstract] [Full Text] [Related]
3. Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients.
Tadokoro T; Nomura T; Fujita K; Manabe T; Takuma K; Nakahara M; Oura K; Mimura S; Tani J; Morishita A; Kobara H; Ono M; Masaki T
BMC Gastroenterol; 2024 Apr; 24(1):123. PubMed ID: 38561671
[TBL] [Abstract] [Full Text] [Related]
4. Differential expression of circular RNAs in human umbilical cord mesenchymal stem cells treated with icariin.
Liu X; Chu X; Li L; Man S; Wang L; Bian Y; Zhou H
Medicine (Baltimore); 2024 Mar; 103(12):e37549. PubMed ID: 38517991
[TBL] [Abstract] [Full Text] [Related]
5. Real-World treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
[TBL] [Abstract] [Full Text] [Related]
6. Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: The Effectiveness of Different Particle Sizes in Downstaging and Bridging in Living Donor liver Transplantation.
Lim WX; Sim KS; Chen CL; Ou HY; Yu CY; Cheng YF
Transplant Proc; 2024 Apr; 56(3):596-601. PubMed ID: 38472083
[TBL] [Abstract] [Full Text] [Related]
7. Targeting alk averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma.
Liu C; Zhou C; Xia W; Zhou Y; Qiu Y; Weng J; Zhou Q; Chen W; Wang YN; Lee HH; Wang SC; Kuang M; Yu D; Ren N; Hung MC
Nat Commun; 2024 Feb; 15(1):1009. PubMed ID: 38307859
[TBL] [Abstract] [Full Text] [Related]
8. Case report: Successful sequential therapy of crizotinb and entrectinib in ROS1-positive non-small-cell lung cancer with brain metastasis in later-settings.
Dong W; Zhuge J; Yu P; Liu K; Yang M; Wang H
Medicine (Baltimore); 2023 Dec; 102(51):e36591. PubMed ID: 38134118
[TBL] [Abstract] [Full Text] [Related]
9. The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trial.
Peng W; Yi M; Qi X; Qi W; Li C; Wen T
Trials; 2023 Dec; 24(1):781. PubMed ID: 38042834
[TBL] [Abstract] [Full Text] [Related]
10. Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial.
Wang B; Zhou J; Wu X; Sun Y; Li L; Li P; Li M; Jiang W; Xu M; Feng B; Xu X; Cheng J; Xie W; Han T; Wang X; Li H; Piao H; Zhao X; Chen S; Meng T; Guan Q; Meng F; Kong Y; Ou X; Jia J; You H
Am J Gastroenterol; 2024 Apr; 119(4):700-711. PubMed ID: 37929952
[TBL] [Abstract] [Full Text] [Related]
11. Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma.
Yu Q; Ungchusri E; Pillai A; Liao CY; Baker T; Fung J; DiSabato D; Zhang M; Liao C; Van Ha T; Ahmed O
Eur Radiol; 2024 Apr; 34(4):2374-2383. PubMed ID: 37812295
[TBL] [Abstract] [Full Text] [Related]
12. alk Inhibitor treatment Patterns and Outcomes in Real-World Patients with alk-Positive Non-Small-Cell Lung cancer: A Retrospective Cohort Study.
Wang M; Slatter S; Sussell J; Lin CW; Ogale S; Datta D; Butte AJ; Bazhenova L; Rudrapatna VA
Target Oncol; 2023 Jul; 18(4):571-583. PubMed ID: 37341856
[TBL] [Abstract] [Full Text] [Related]
13. Primary tumor resection improves survival benefit of stage IVB cervical carcinoma: a new perspective.
He Y; Zhang Y; Hu S; Zhang B; Zhang Z; Yao Y; Wang X
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11013-11023. PubMed ID: 37335336
[TBL] [Abstract] [Full Text] [Related]
14. A real-world analysis of survival and cost-effectiveness of sintilimab plus bevacizumab biosimilar regimen in patients with advanced hepatocellular carcinoma.
Zeng X; Jia Y; Chen H; Luo Q; Zhao H; Liang G; Chen W; Li Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9213-9219. PubMed ID: 37188985
[TBL] [Abstract] [Full Text] [Related]
15. Brigatinib pharmacokinetics in patients with chronic hepatic impairment.
Hanley MJ; Kerstein D; Tugnait M; Narasimhan N; Marbury TC; Venkatakrishnan K; Gupta N
Invest New Drugs; 2023 Jun; 41(3):402-410. PubMed ID: 37052729
[TBL] [Abstract] [Full Text] [Related]
16. [Alectinib and mixed large cell neuroendocrine carcinoma of the lung.].
Hegedűs F; Sükösd F; Tiszlavicz L; Furák J; Pálföldi R; Fejes Z; Zombori T
Orv Hetil; 2023 Apr; 164(14):548-554. PubMed ID: 37031440
[TBL] [Abstract] [Full Text] [Related]
17. Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab.
Li S; Yuan L; Yue M; Xu Y; Liu S; Wang F; Liu X; Wang F; Deng J; Sun Q; Liu X; Xue C; Lu T; Zhang W; Zhou J
Cancer Imaging; 2023 Mar; 23(1):30. PubMed ID: 36964617
[TBL] [Abstract] [Full Text] [Related]
18. Successful treatment with Crizotinib to Overcome Drug Resistance Possibly Due to Mesenchymal-epithelial Transition Amplification in a Lung cancer Patient with the Echinoderm Microtubule-associated Protein-like 4-anaplastic Lymphoma Kinase Fusion Gene.
Shiraishi T; Yamasaki K; Kidogawa M; Shingu T; Ujimiya F; Jotatsu T; Matsumoto S; Izumi H; Nishida C; Goto K; Yatera K
Intern Med; 2023 Nov; 62(21):3215-3221. PubMed ID: 36927974
[TBL] [Abstract] [Full Text] [Related]
19. Multisystem alk-positive histiocytosis: a multi-case study and literature review.
Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
[TBL] [Abstract] [Full Text] [Related]
20. The safety profile of EGFR/alk-TKIs administered immediately before or after ICIs in advanced NSCLC.
Liao D; Yu L; Chen S; Liu N; Tang J; Yang N
Int Immunopharmacol; 2023 Mar; 116():109787. PubMed ID: 36774856
[TBL] [Abstract] [Full Text] [Related]
[Next]
